title: Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
abstract: Hollingsworth and Isturiz (1) have raised several questions about our earlier review of the use of pneumococcal conjugate (PCV) or polysaccharide (PPV) vaccine for older adults (i.e., ≥65 y of age). (2) They begin by citing two metaanalyses published in 2009 and 2013 that concluded that prevention of pneumococcal pneumonia could not be demonstrated for PPV. (3)(,) (4) They overlook my earlier review of five metaanalyses that was published in 2004. (5) This review showed that the study populations in prospective trials of PPV were often not representative of the populations of elderly and high-risk adults for whom PPV is recommended. Furthermore, the five metaanalyses often omitted clinical trials that should have been evaluated, included trials that should have been omitted, and frequently miscounted the numbers of subjects and outcome events in the individual clinical trials. More important, retrospective sample size calculations showed that none of the five metaanalyses included an adequate number of person years of observation to rule out false-negative results. The numbers speak for themselves and cannot be ignored. Simply put, metaanalyses of the PPV clinical trials will never tell us whether the vaccine prevents pneumococcal pneumonia or all-cause pneumonia in elderly and high-risk adults, and consequently they must be regarded as inconclusive and uninformative. Since 2004, only one small prospective clinical trial of PPV has been published (reviewed in 6). Nothing new has been added to our knowledge of PPV efficacy by the more recent metaanalyses. (3)(,) (4) Epidemiologists have reminded us that the lack of evidence of PPV efficacy is not evidence of its absence. The conclusions of our earlier review still stand. (5.)
authors.affiliation: Sergy Haut, France.
authors.forename: David S
authors.initials: DS
authors.lastname: Fedson
mesh_terms: D006801:Humans; D022242:Pneumococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D014611:Vaccination / Q000379:methods*
chemical_list: D022242:Pneumococcal Vaccines
references.citation: Am J Prev Med. 2013 Apr;44(4):373-381
references.pmid: 23498103
references.citation: JAMA. 2012 Feb 22;307(8):804-12
references.pmid: 22357831
references.citation: Clin Infect Dis. 2009 Jul 15;49(2):205-12
references.pmid: 19508165
references.citation: MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6
references.pmid: 20814406
references.citation: Clin Infect Dis. 2012 Jul;55(2):265-7
references.pmid: 22495544
references.citation: Eur J Clin Microbiol Infect Dis. 2007 Aug;26(8):531-40
references.pmid: 17570001
references.citation: mBio. 2011 Jan 25;2(1):e00309-10
references.pmid: 21264063
references.citation: Lancet Infect Dis. 2011 Oct;11(10):760-8
references.pmid: 21621466
references.citation: CMAJ. 2009 Jan 6;180(1):48-58
references.pmid: 19124790
references.citation: Vaccine. 2004 Feb 25;22(8):927-46
references.pmid: 15161070
references.citation: Vaccine. 2011 Aug 26;29(37):6149-54
references.pmid: 21763386
references.citation: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD000422
references.pmid: 23440780
references.citation: Clin Microbiol Infect. 2009 Nov;15(11):1013-9
references.pmid: 19673968
references.citation: Neth J Med. 2008 Oct;66(9):378-83
references.pmid: 18990781
references.citation: Hum Vaccin Immunother. 2014;10(1):45-6
references.pmid: 24018552
references.citation: Clin Infect Dis. 2009 Nov 1;49(9):1318-25
references.pmid: 19814624
references.citation: Expert Rev Vaccines. 2011 Aug;10(8):1143-67
references.pmid: 21810065
references.citation: Vaccine. 2012 Aug 3;30(36):5437-44
references.pmid: 22728289
references.citation: Clin Infect Dis. 2011 Mar 1;52(5):633-40
references.pmid: 21292668
references.citation: Hum Vaccin. 2011 Sep;7(9):919-28
references.pmid: 21860256
references.citation: N Engl J Med. 2013 Jul 11;369(2):155-63
references.pmid: 23841730
references.citation: Hum Vaccin Immunother. 2013 Jun;9(6):1382-4
references.pmid: 23732892
references.citation: J Infect Dis. 2010 Jan 1;201(1):32-41
references.pmid: 19947881
references.citation: Trans Assoc Am Physicians. 1976;89:184-94
references.pmid: 14433